Effects of cancer screening restart strategies after COVID-19 disruption

Autor: Eveline A.M. Heijnsdijk, Iris Lansdorp-Vogelaar, Sylvia Kaljouw, Elisabeth F. P. Peterse, L. De Jonge, I. M. C. M. de Kok, Erik E.L. Jansen, N. T. van Ravesteyn, Lindy M. Kregting
Přispěvatelé: Public Health
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Adult
Male
2019-20 coronavirus outbreak
Cancer Research
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Colorectal cancer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Uterine Cervical Neoplasms
Breast Neoplasms
Age limit
Article
Cancer screening
Population screening
03 medical and health sciences
0302 clinical medicine
PROFFERED PAPER SESSION: Measuring Impact of COVID-19 on Breast Cancer Care
SDG 3 - Good Health and Well-being
medicine
Humans
030212 general & internal medicine
Intensive care medicine
Pandemics
Early Detection of Cancer
Aged
SARS-CoV-2
business.industry
Incidence (epidemiology)
COVID-19
Correction
Cancer
Middle Aged
medicine.disease
Virology
Health policy
Oncology
Cancer incidence
Colorectal cancer screening
030220 oncology & carcinogenesis
Female
Colorectal Neoplasms
business
Zdroj: British Journal of Cancer
European Journal of Cancer
British Journal of Cancer, 124(9), 1516-1523. Nature Publishing Group
Web of Science
ISSN: 1532-1827
0007-0920
Popis: Background Many breast, cervical, and colorectal cancer screening programmes were disrupted due to the COVID-19 pandemic. This study aimed to estimate the effects of five restart strategies after the disruption on required screening capacity and cancer burden. Methods Microsimulation models simulated five restart strategies for breast, cervical, and colorectal cancer screening. The models estimated required screening capacity, cancer incidence, and cancer-specific mortality after a disruption of 6 months. The restart strategies varied in whether screens were caught up or not and, if so, immediately or delayed, and whether the upper age limit was increased. Results The disruption in screening programmes without catch-up of missed screens led to an increase of 2.0, 0.3, and 2.5 cancer deaths per 100 000 individuals in 10 years in breast, cervical, and colorectal cancer, respectively. Immediately catching-up missed screens minimised the impact of the disruption but required a surge in screening capacity. Delaying screening, but still offering all screening rounds gave the best balance between required capacity, incidence, and mortality. Conclusions Strategies with the smallest loss in health effects were also the most burdensome for the screening organisations. Which strategy is preferred depends on the organisation and available capacity in a country.
Databáze: OpenAIRE
Externí odkaz: